A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia
Clinical trial NCT01626859 · COMPLETED
Trial details
- NCT number
- NCT01626859
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-08-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.